[go: up one dir, main page]

ATE48843T1 - 2-amino-1,9-dihydro-6h-purin-6-one-7-oxyde, die pharmazeutisch vertraeglichen salze und ein verfahren zu ihrer herstellung. - Google Patents

2-amino-1,9-dihydro-6h-purin-6-one-7-oxyde, die pharmazeutisch vertraeglichen salze und ein verfahren zu ihrer herstellung.

Info

Publication number
ATE48843T1
ATE48843T1 AT84306794T AT84306794T ATE48843T1 AT E48843 T1 ATE48843 T1 AT E48843T1 AT 84306794 T AT84306794 T AT 84306794T AT 84306794 T AT84306794 T AT 84306794T AT E48843 T1 ATE48843 T1 AT E48843T1
Authority
AT
Austria
Prior art keywords
purin
dihydro
amino
compound
pharmaceutically acceptable
Prior art date
Application number
AT84306794T
Other languages
English (en)
Inventor
Josephino Ballesteros Tunac
Gerard Clifford Hokanson
Donald L Kern
James Clark French
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE48843T1 publication Critical patent/ATE48843T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/826—Actinomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT84306794T 1983-10-06 1984-10-05 2-amino-1,9-dihydro-6h-purin-6-one-7-oxyde, die pharmazeutisch vertraeglichen salze und ein verfahren zu ihrer herstellung. ATE48843T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/539,517 US4551529A (en) 1983-10-06 1983-10-06 Guanine-N7 -oxide
EP84306794A EP0136923B1 (de) 1983-10-06 1984-10-05 2-Amino-1,9-dihydro-6H-Purin-6-one-7-oxyde, die pharmazeutisch verträglichen Salze und ein Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE48843T1 true ATE48843T1 (de) 1990-01-15

Family

ID=24151561

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84306794T ATE48843T1 (de) 1983-10-06 1984-10-05 2-amino-1,9-dihydro-6h-purin-6-one-7-oxyde, die pharmazeutisch vertraeglichen salze und ein verfahren zu ihrer herstellung.

Country Status (5)

Country Link
US (1) US4551529A (de)
EP (1) EP0136923B1 (de)
JP (1) JPS60142985A (de)
AT (1) ATE48843T1 (de)
DE (1) DE3480792D1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0633263B2 (ja) * 1985-05-27 1994-05-02 鐘淵化学工業株式会社 ７−ヒドロキシグアニン誘導体及びその製造方法並びにそれを有効成分とする抗腫瘍剤
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Also Published As

Publication number Publication date
JPS60142985A (ja) 1985-07-29
US4551529A (en) 1985-11-05
EP0136923B1 (de) 1989-12-20
DE3480792D1 (de) 1990-01-25
EP0136923A2 (de) 1985-04-10
EP0136923A3 (en) 1986-02-05

Similar Documents

Publication Publication Date Title
DE3479661D1 (en) Antibiotic/antitumor compounds and their production
ES8105149A1 (es) Un procedimiento para la preparacion de la mezcla antibioti-ca a-42355
ATE196655T1 (de) Ein verfahren zur herstellung von immunosuppressiva und eine neuartige mikrobielle spezies, die dabei eingesetzt wird
ES8706162A1 (es) Procedimiento de obtencion de antibiotico designado por cl-1577-b4
ATE48843T1 (de) 2-amino-1,9-dihydro-6h-purin-6-one-7-oxyde, die pharmazeutisch vertraeglichen salze und ein verfahren zu ihrer herstellung.
ES8700316A1 (es) Un procedimiento para la preparacion de compuesto denominado cl-1724b-2
EP0139457A3 (de) Antibiotische Verbindung und ihre Herstellung
DE3866733D1 (de) Azoxyverbindungen und verfahren zu ihrer herstellung.
ES382658A1 (es) Procedimiento de produccion de un nuevo antibiotico.
ATE131169T1 (de) 2-pyranon-derivat und verfahren zu dessen herstellung.
ATE111092T1 (de) Antibiotikum a80915 und verfahren zu seiner herstellung.
KR920002795A (ko) 항생제 발히마이신, 이의 제조방법 및 약제로서 이의 용도
HUT50360A (en) Process for producing antibiotic uk-61689 by microbiological way and pharmaceutical composition comprising the active ingredient and mycelium
DD210709A1 (de) Verfahren zur herstellung des antibiotikums a51568 mit den faktoren a und b
ES485529A1 (es) Un procedimiento para la produccion de ravidomicina
KR860002574A (ko) 항생물질 at 2433 복합체의 제조방법
IE45014L (en) Antibiotic a-7413.
ATE147105T1 (de) Verfahren zur selektiven verbesserten herstellung des antibiotikum ge 2270 faktor a
GB1382316A (en) Fermentation for producing an antibiotic
ES436177A1 (es) Un procedimiento para la preparacion de nuevos antibioticos homologos de la iasalocida a.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee